Neuren Pharmaceuticals
(ASX) NEU
Neuren Pharmaceuticals Financials at a Glance
Market Cap
$1.51B
Revenue (TTM)
$281.47M
Net Income (TTM)
$172.48M
EPS (TTM)
$0.23
P/E Ratio
50.04
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Price
$12.03
Volume
436,301
Open
$12.38
Price
$12.03
Volume
436,301
Open
$12.38
Previous Close
$12.03
Daily Range
$11.83 - $12.40
52-Week Range
$8.61 - $22.98
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Price
$12.03
Volume
436,301
Open
$12.38
Previous Close
$12.03
Daily Range
$11.83 - $12.40
52-Week Range
$8.61 - $22.98
NEU News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Neuren Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareCEO
Jon Pilcher
Website
www.neurenpharma.comHeadquarters
Camberwell, VIC 3124, AU
NEU Financials
Key Financial Metrics (TTM)
Gross Margin
77%
Operating Margin
11%
Net Income Margin
47%
Return on Equity
9%
Return on Capital
2%
Return on Assets
9%
Earnings Yield
2.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.51B
Shares Outstanding
125.14M
Volume
436.30K
Short Interest
0.00%
Avg. Volume
529.11K
Financials (TTM)
Gross Profit
$64.61M
Operating Income
$22.02M
EBITDA
$22.05M
Operating Cash Flow
$125.42M
Capital Expenditure
$37.00K
Free Cash Flow
$125.39M
Cash & ST Invst.
$296.12M
Total Debt
$0.00
Neuren Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$36.36M
-78.5%
Gross Profit
$36.34M
-76.3%
Gross Margin
99.97%
N/A
Market Cap
$1.51B
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$15.40M
-85.9%
EBITDA
$11.14M
-92.6%
Quarterly Fundamentals
Net Cash
$296.12M
+29.6%
Accounts Receivable
$26.54M
+84.2%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
8.88%
N/A
Return on Invested Capital
2.11%
N/A
Free Cash Flow
$2.92M
-102.1%
Operating Cash Flow
$2.88M
-102.1%